SCIO-469

· Scios, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for SCIO-469, covering 2010-04-27 to 2013-11-07. Get the full timeline:

Most recent: Clinical Trial Update: SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. [Phase 2]